You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

Review
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1

 

Online download statistics by month:

Online download statistics by month: January 2021 to January 2026

AbstractFullPdf
Jan 2021477477283
Feb 2021401402186
Mar 2021232232151
Apr 2021223223113
May 202122722794
Jun 202127127194
Jul 202122922998
Aug 2021250250103
Sep 202126926998
Oct 2021242242120
Nov 2021244243106
Dec 2021279285103
Jan 202219120293
Feb 2022170182128
Mar 2022199209101
Apr 202215115789
May 202218519497
Jun 202217218283
Jul 202212813254
Aug 202216216656
Sep 202213814479
Oct 202215215588
Nov 202214614876
Dec 202211711744
Jan 202311211362
Feb 202321822396
Mar 202314514567
Apr 202311411643
May 202311011045
Jun 202311811947
Jul 202312612864
Aug 2023969835
Sep 20239710141
Oct 202312312443
Nov 202317817965
Dec 202325925941
Jan 202412212369
Feb 202413913938
Mar 2024194199117
Apr 202425625959
May 20249710049
Jun 202411911837
Jul 2024979849
Aug 2024676733
Sep 2024656644
Oct 2024889266
Nov 20249810250
Dec 202418621564
Jan 202511512155
Feb 202521722358
Mar 202511511571
Apr 202515716037
May 202517618542
Jun 2025717420
Jul 2025110
Jan 2026110
Total933295114144